Alzheimer’s disease (AD) is a neurodegenerative disorder marked by amyloid-β (Aβ) plaques and tau-containing neurofibrillary tangles, leading to progressive cognitive decline and behavioral changes [1]. This evidence concerns the gene MAPT and Alzheimer disease.